Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.
Blue Bird Corp (NASDAQ: BLBD) shares are trading higher in Monday's after-hours session after the company reported better-than-expected fourth-quarter financial results and increased full-year 2024 revenue guidance.